Logo image of THC

TENET HEALTHCARE CORP (THC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:THC - US88033G4073 - Common Stock

188.78 USD
-0.67 (-0.35%)
Last: 1/23/2026, 8:04:00 PM
188.78 USD
0 (0%)
After Hours: 1/23/2026, 8:04:00 PM
Fundamental Rating

6

THC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. THC has an excellent profitability rating, but there are some minor concerns on its financial health. THC is valued quite cheap, while showing a decent growth score. This is a good combination! This makes THC very considerable for value investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • THC had positive earnings in the past year.
  • In the past year THC had a positive cash flow from operations.
  • THC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years THC had a positive operating cash flow.
THC Yearly Net Income VS EBIT VS OCF VS FCFTHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

  • THC has a Return On Assets of 4.60%. This is in the better half of the industry: THC outperforms 74.51% of its industry peers.
  • Looking at the Return On Equity, with a value of 33.73%, THC belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
  • THC has a Return On Invested Capital of 11.65%. This is amongst the best in the industry. THC outperforms 85.29% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for THC is in line with the industry average of 9.21%.
  • The last Return On Invested Capital (11.65%) for THC is above the 3 year average (9.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.6%
ROE 33.73%
ROIC 11.65%
ROA(3y)4.91%
ROA(5y)3.9%
ROE(3y)50.24%
ROE(5y)332.92%
ROIC(3y)9.25%
ROIC(5y)8.01%
THC Yearly ROA, ROE, ROICTHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.49%, THC belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
  • THC's Profit Margin has improved in the last couple of years.
  • THC has a Operating Margin of 17.52%. This is amongst the best in the industry. THC outperforms 96.08% of its industry peers.
  • THC's Operating Margin has improved in the last couple of years.
  • THC has a Gross Margin of 82.26%. This is amongst the best in the industry. THC outperforms 96.08% of its industry peers.
  • THC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.52%
PM (TTM) 6.49%
GM 82.26%
OM growth 3Y10.99%
OM growth 5Y11.36%
PM growth 3Y48.9%
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.27%
THC Yearly Profit, Operating, Gross MarginsTHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so THC is still creating some value.
  • Compared to 1 year ago, THC has less shares outstanding
  • Compared to 5 years ago, THC has less shares outstanding
  • Compared to 1 year ago, THC has an improved debt to assets ratio.
THC Yearly Shares OutstandingTHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
THC Yearly Total Debt VS Total AssetsTHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • THC has an Altman-Z score of 1.84. This is not the best score and indicates that THC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • THC has a Altman-Z score of 1.84. This is comparable to the rest of the industry: THC outperforms 44.12% of its industry peers.
  • THC has a debt to FCF ratio of 8.78. This is a slightly negative value and a sign of low solvency as THC would need 8.78 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.78, THC is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • A Debt/Equity ratio of 3.26 is on the high side and indicates that THC has dependencies on debt financing.
  • THC's Debt to Equity ratio of 3.26 is on the low side compared to the rest of the industry. THC is outperformed by 74.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.26
Debt/FCF 8.78
Altman-Z 1.84
ROIC/WACC1.34
WACC8.7%
THC Yearly LT Debt VS Equity VS FCFTHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.71 indicates that THC should not have too much problems paying its short term obligations.
  • THC has a Current ratio of 1.71. This is in the better half of the industry: THC outperforms 68.63% of its industry peers.
  • THC has a Quick Ratio of 1.64. This is a normal value and indicates that THC is financially healthy and should not expect problems in meeting its short term obligations.
  • THC has a better Quick ratio (1.64) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.64
THC Yearly Current Assets VS Current LiabilitesTHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 39.32% over the past year.
  • The Earnings Per Share has been growing by 34.84% on average over the past years. This is a very strong growth
  • THC shows a decrease in Revenue. In the last year, the revenue decreased by -0.56%.
  • The Revenue has been growing slightly by 2.26% on average over the past years.
EPS 1Y (TTM)39.32%
EPS 3Y16.22%
EPS 5Y34.84%
EPS Q2Q%26.28%
Revenue 1Y (TTM)-0.56%
Revenue growth 3Y1.98%
Revenue growth 5Y2.26%
Sales Q2Q%3.26%

3.2 Future

  • THC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.65% yearly.
  • Based on estimates for the next years, THC will show a small growth in Revenue. The Revenue will grow by 3.27% on average per year.
EPS Next Y36.76%
EPS Next 2Y18.31%
EPS Next 3Y15.68%
EPS Next 5Y13.65%
Revenue Next Year2.31%
Revenue Next 2Y3.32%
Revenue Next 3Y3.84%
Revenue Next 5Y3.27%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
THC Yearly Revenue VS EstimatesTHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
THC Yearly EPS VS EstimatesTHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.16 indicates a correct valuation of THC.
  • 84.31% of the companies in the same industry are more expensive than THC, based on the Price/Earnings ratio.
  • THC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.21.
  • Based on the Price/Forward Earnings ratio of 11.33, the valuation of THC can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of THC indicates a rather cheap valuation: THC is cheaper than 87.25% of the companies listed in the same industry.
  • THC is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.16
Fwd PE 11.33
THC Price Earnings VS Forward Price EarningsTHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, THC is valued cheaply inside the industry as 90.20% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, THC is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.05
EV/EBITDA 6
THC Per share dataTHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • THC has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as THC's earnings are expected to grow with 15.68% in the coming years.
PEG (NY)0.33
PEG (5Y)0.35
EPS Next 2Y18.31%
EPS Next 3Y15.68%

0

5. Dividend

5.1 Amount

  • THC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TENET HEALTHCARE CORP / THC FAQ

What is the ChartMill fundamental rating of TENET HEALTHCARE CORP (THC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to THC.


What is the valuation status for THC stock?

ChartMill assigns a valuation rating of 9 / 10 to TENET HEALTHCARE CORP (THC). This can be considered as Undervalued.


Can you provide the profitability details for TENET HEALTHCARE CORP?

TENET HEALTHCARE CORP (THC) has a profitability rating of 9 / 10.


What is the valuation of TENET HEALTHCARE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TENET HEALTHCARE CORP (THC) is 12.16 and the Price/Book (PB) ratio is 4.13.


Can you provide the expected EPS growth for THC stock?

The Earnings per Share (EPS) of TENET HEALTHCARE CORP (THC) is expected to grow by 36.76% in the next year.